Vivo Capital, LLC
Filing Date
Global Rank
#1,370
/ 8,232
▲ 70
Top Industry
Biotechnology
99.6%
3Y Alpha vs SPY
+1.0%
Period ended 2 months ago
Filed May 20, 2026 · 24d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+80.9%
SPY
+76.5%
Annualised alpha
+1.0%
Max drawdown
−40.2%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
44 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
16.9%
−0.6 pts
Top 5
42.3%
+0.9 pts
Top 10
61.3%
+1.2 pts
HHI
596
Diversified−2
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,164,469,705 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
5 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ERAS | Erasca, Inc. | +2,878,052 | 12,151,480 | $196,610,946 | |
| CRVS | Corvus Pharmaceuticals, Inc. | +571,250 | 2,805,816 | $41,049,088 | |
| DBVT | DBV Technologies S.A. | +205,943 | 2,667,569 | $55,725,516 | |
| DRUG | Bright Minds Biosciences Inc. | +55,555 | 557,172 | $40,656,840 | |
| PRAX | Praxis Precision Medicines, Inc. | +10,000 | 338,895 | $109,188,580 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
9 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| GERN | Geron Corp | −18,553,495 | 8,671,797 | $12,920,977 | |
| TERN | Terns Pharmaceuticals, Inc. | −4,012,510 | 1,334,418 | $70,350,516 | |
| ACRS | Aclaris Therapeutics, Inc. | −2,222,222 | 6,666,666 | $24,999,997 | |
| COGT | Cogent Biosciences, Inc. | −1,976,693 | 422,300 | $16,254,327 | |
| DYN | Dyne Therapeutics, Inc. | −1,057,494 | 1,557,466 | $28,236,858 | |
| VRDN | Viridian Therapeutics, Inc.DE | −816,288 | 166,288 | $3,252,593 | |
| SLNO | Soleno Therapeutics Inc | −600,000 | 294,909 | $9,873,553 | |
| ORIC | Oric Pharmaceuticals, Inc. | −269,598 | 1,848,786 | $23,424,118 | |
| ABVX | Abivax S.A. | −119,766 | 239,539 | $26,672,667 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
8 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SNSE | Sensei Biotherapeutics, Inc. | 722,020 | $22,758,070 | |
| AVBP | ArriVent BioPharma, Inc. | 885,916 | $20,438,082 | |
| MANE | Veradermics, Inc | 300,000 | $18,945,000 | |
| ANTX | AN2 Therapeutics, Inc. | 3,153,640 | $10,785,448 | |
| OKUR | OnKure Therapeutics, Inc. | 1,927,710 | $7,980,719 | |
| ALXO | Alx Oncology Holdings Inc | 3,184,713 | $6,385,349 | |
| MSLE | Satellos Bioscience Inc. | 813,666 | $4,580,939 | |
| CMPS | COMPASS Pathways plc | 200,000 | $1,106,000 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ZBIO | Zenas BioPharma, Inc. | 853,495 | $30,990,403 | |
| CTMX | CytomX Therapeutics, Inc. | 2,884,615 | $12,288,459 | |
| ABEO | Abeona Therapeutics Inc. | 1,842,751 | $9,711,297 | |
| VSTM | Verastem, Inc. | 1,106,524 | $8,542,365 | |
| SLN | Silence Therapeutics plc | 1,105,454 | $6,721,160 | |
| PALI | Palisade Bio, Inc. | 2,293,578 | $5,389,908 | |
| No positions match the current search. | ||||
44 positions ·
$1,164,469,705 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ERAS |
Erasca, Inc.
Healthcare
|
Added | 12,151,480 | $196,610,946 | 16.88% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 338,895 | $109,188,580 | 9.38% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,334,418 | $70,350,516 | 6.04% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Held | 5,094,668 | $60,779,389 | 5.22% | |
| DBVT |
DBV Technologies S.A.
Healthcare
|
Added | 2,667,569 | $55,725,516 | 4.79% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Held | 9,545,466 | $50,495,515 | 4.34% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Held | 2,154,780 | $45,077,997 | 3.87% | |
| SABS |
SAB Biotherapeutics, Inc.
Healthcare
|
Held | 11,420,000 | $43,738,600 | 3.76% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
Added | 2,805,816 | $41,049,088 | 3.53% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Added | 557,172 | $40,656,840 | 3.49% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Held | 353,998 | $29,707,512 | 2.55% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Reduced | 1,557,466 | $28,236,858 | 2.42% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 239,539 | $26,672,667 | 2.29% | |
| NERV |
Minerva Neurosciences, Inc.
Healthcare
|
Held | 4,322,747 | $26,044,550 | 2.24% | |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
Reduced | 6,666,666 | $24,999,997 | 2.15% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,848,786 | $23,424,118 | 2.01% | |
| ANRO |
Alto Neuroscience, Inc.
Healthcare
|
Held | 1,035,551 | $23,279,186 | 2.00% | |
| SNSE |
Sensei Biotherapeutics, Inc.
Healthcare
|
NEW | 722,020 | $22,758,070 | 1.95% | |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
NEW | 885,916 | $20,438,082 | 1.76% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
Held | 800,000 | $19,728,000 | 1.69% | |
| MANE |
Veradermics, Inc
Healthcare
|
NEW | 300,000 | $18,945,000 | 1.63% | |
| CAMP |
Camp4 Therapeutics Corp
Healthcare
|
Held | 4,246,568 | $18,727,364 | 1.61% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Held | 1,000,000 | $18,640,000 | 1.60% | |
| DSGN |
Design Therapeutics, Inc.
Healthcare
|
Held | 1,612,903 | $17,161,287 | 1.47% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 422,300 | $16,254,327 | 1.40% | |
| GERN |
Geron Corp
Healthcare
|
Reduced | 8,671,797 | $12,920,977 | 1.11% | |
| UNCY |
Unicycive Therapeutics, Inc.
Healthcare
|
Held | 1,789,916 | $11,777,647 | 1.01% | |
| ANTX |
AN2 Therapeutics, Inc.
Healthcare
|
NEW | 3,153,640 | $10,785,448 | 0.93% | |
| OLMA |
Olema Pharmaceuticals, Inc.
Healthcare
|
Held | 671,843 | $10,017,179 | 0.86% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Reduced | 294,909 | $9,873,553 | 0.85% | |
| EPRX |
Eupraxia Pharmaceuticals Inc.
Healthcare
|
Held | 1,350,000 | $9,774,000 | 0.84% | |
| OKUR |
OnKure Therapeutics, Inc.
Healthcare
|
NEW | 1,927,710 | $7,980,719 | 0.69% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
Held | 260,000 | $7,573,800 | 0.65% | |
| ALXO |
Alx Oncology Holdings Inc
Healthcare
|
NEW | 3,184,713 | $6,385,349 | 0.55% | |
| MNPR |
Monopar Therapeutics
Healthcare
|
Held | 90,500 | $4,958,495 | 0.43% | |
| MSLE |
Satellos Bioscience Inc.
Healthcare
|
NEW | 813,666 | $4,580,939 | 0.39% | |
| PEPG |
PepGen Inc.
Healthcare
|
Held | 2,325,000 | $4,115,250 | 0.35% | |
| SERA |
Sera Prognostics, Inc.
Healthcare
|
Held | 1,650,440 | $3,350,393 | 0.29% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
Held | 208,333 | $3,331,244 | 0.29% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
Reduced | 166,288 | $3,252,593 | 0.28% | |
| TIL |
Instil Bio, Inc.
Healthcare
|
Held | 292,743 | $2,412,202 | 0.21% | |
| KTTA |
Pasithea Therapeutics Corp.
Healthcare
|
Held | 2,100,000 | $1,558,200 | 0.13% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
NEW | 200,000 | $1,106,000 | 0.09% | |
| DTIL |
Precision Biosciences Inc
Healthcare
|
Held | 4,675 | $25,712 | 0.00% |